Retrospective analysis of ribociclib and letrozole as first-line therapy in patients with hormone receptor (HR) positive metastatic breast cancer (MBC) within a managed access program (MAP) in Turkey.
dc.authorid | Eralp, Yesim/0000-0001-9603-4755 | |
dc.authorid | Gokmen, Erhan/0000-0003-4596-2986 | |
dc.authorid | Aktas, Burak Yasin/0000-0001-5460-4895; | |
dc.authorwosid | Eralp, Yesim/AAD-7194-2020 | |
dc.authorwosid | Gokmen, Erhan/HKE-3549-2023 | |
dc.authorwosid | Coşkun, Hasan Şenol/C-2070-2016 | |
dc.authorwosid | Aktas, Burak Yasin/AAA-4726-2022 | |
dc.authorwosid | Sendur, Mehmet Ali Nahit/H-7555-2014 | |
dc.authorwosid | Gokmen, Erhan/HKM-3785-2023 | |
dc.contributor.author | Basaran, Gul | |
dc.contributor.author | Demirci, Umut | |
dc.contributor.author | Yildiz, Fatih | |
dc.contributor.author | Cicin, Irfan | |
dc.contributor.author | Aktas, Burak Yasin | |
dc.contributor.author | Ozturk, Banu | |
dc.contributor.author | Goksu, Sema Sezgin | |
dc.date.accessioned | 2024-06-12T11:24:00Z | |
dc.date.available | 2024-06-12T11:24:00Z | |
dc.date.issued | 2020 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description | Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 29-31, 2020 -- ELECTR NETWORK | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | Amer Soc Clin Oncol | en_US |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.issue | 15 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/26767 | |
dc.identifier.volume | 38 | en_US |
dc.identifier.wos | WOS:000560368304194 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Journal Of Clinical Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keywords] | en_US |
dc.title | Retrospective analysis of ribociclib and letrozole as first-line therapy in patients with hormone receptor (HR) positive metastatic breast cancer (MBC) within a managed access program (MAP) in Turkey. | en_US |
dc.type | Conference Object | en_US |